Robin N. Thompson

6.5k total citations · 2 hit papers
108 papers, 2.5k citations indexed

About

Robin N. Thompson is a scholar working on Modeling and Simulation, Infectious Diseases and Epidemiology. According to data from OpenAlex, Robin N. Thompson has authored 108 papers receiving a total of 2.5k indexed citations (citations by other indexed papers that have themselves been cited), including 66 papers in Modeling and Simulation, 53 papers in Infectious Diseases and 24 papers in Epidemiology. Recurrent topics in Robin N. Thompson's work include COVID-19 epidemiological studies (65 papers), Viral Infections and Outbreaks Research (28 papers) and SARS-CoV-2 and COVID-19 Research (23 papers). Robin N. Thompson is often cited by papers focused on COVID-19 epidemiological studies (65 papers), Viral Infections and Outbreaks Research (28 papers) and SARS-CoV-2 and COVID-19 Research (23 papers). Robin N. Thompson collaborates with scholars based in United Kingdom, United States and Japan. Robin N. Thompson's co-authors include Sophie Witter, William S. Hart, Nik J. Cunniffe, Christopher A. Gilligan, Philip K. Maini, Uri Obolski, Sebastian Funk, Jonathan A. Polonsky, Justin Lessler and Nick Andrews and has published in prestigious journals such as Proceedings of the National Academy of Sciences, The Lancet and Nature Communications.

In The Last Decade

Robin N. Thompson

98 papers receiving 2.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Improved inference of time-varying reproduction numbers during infectious disease outbreaks

2019 293 citations Robin N. Thompson, Jonathan A. Polonsky et al. Epidemics profile →
Generation time of the alpha and delta SARS-CoV-2 variants: an epidemiological analysis

2022 141 citations William S. Hart, Robin N. Thompson et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Robin N. Thompson United Kingdom	26	1.3k	882	471	406	359	108	2.5k
Abhishek Pandey United States	22	1.1k 0.9×	1.0k 1.2×	396 0.8×	360 0.9×	322 0.9×	62	2.3k
Pratha Sah United States	24	1.0k 0.8×	925 1.0×	297 0.6×	210 0.5×	315 0.9×	39	2.4k
Bryan Lewis United States	24	1.8k 1.4×	997 1.1×	937 2.0×	428 1.1×	421 1.2×	85	3.1k
Ashleigh R. Tuite Canada	29	1.3k 1.0×	1.2k 1.3×	990 2.1×	498 1.2×	253 0.7×	124	3.3k
Meagan C. Fitzpatrick United States	26	1.1k 0.9×	1.5k 1.7×	606 1.3×	346 0.9×	295 0.8×	66	2.9k
Christian L. Althaus Switzerland	30	1.3k 1.0×	1.4k 1.6×	621 1.3×	532 1.3×	360 1.0×	80	3.5k
Nick Ruktanonchai United States	24	1.2k 1.0×	471 0.5×	450 1.0×	505 1.2×	439 1.2×	45	2.3k
Eunha Shim South Korea	27	1.0k 0.8×	732 0.8×	486 1.0×	437 1.1×	261 0.7×	63	2.0k
Jonathan M. Read United Kingdom	28	1.5k 1.2×	1.2k 1.4×	1.1k 2.2×	485 1.2×	250 0.7×	93	3.4k

Countries citing papers authored by Robin N. Thompson

Since Specialization

Citations

This map shows the geographic impact of Robin N. Thompson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robin N. Thompson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robin N. Thompson more than expected).

Fields of papers citing papers by Robin N. Thompson

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robin N. Thompson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robin N. Thompson. The network helps show where Robin N. Thompson may publish in the future.

Co-authorship network of co-authors of Robin N. Thompson

This figure shows the co-authorship network connecting the top 25 collaborators of Robin N. Thompson. A scholar is included among the top collaborators of Robin N. Thompson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Robin N. Thompson. Robin N. Thompson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Steyn, Nicholas, Kris V. Parag, Robin N. Thompson, & Christl A. Donnelly. (2025). A Primer on Inference and Prediction With Epidemic Renewal Models and Sequential Monte Carlo. Statistics in Medicine. 44(18-19). e70204–e70204.

Thompson, Robin N., et al.. (2025). Modeling vaccination prioritization strategies for post-pandemic COVID-19 in the Republic of Korea accounting for under-reporting and age-structure. Journal of Infection and Public Health. 18(4). 102688–102688. 1 indexed citations

Hart, William S., et al.. (2025). Effects of individual variation and seasonal vaccination on disease risks. Nature Communications. 16(1). 8471–8471.

Miura, Fuminari, Masahiro Ishikane, Noriko Iwamoto, et al.. (2025). Modeling lesion transition dynamics to clinically characterize patients with clade I mpox in the Democratic Republic of the Congo. Science Translational Medicine. 17(805). eads4773–eads4773.

Hart, William S., et al.. (2023). Exact calculation of end-of-outbreak probabilities using contact tracing data. Journal of The Royal Society Interface. 20(209). 20230374–20230374. 6 indexed citations

Lafferty, Erin I., et al.. (2023). A target-cell limited model can reproduce influenza infection dynamics in hosts with differing immune responses. Journal of Theoretical Biology. 567. 111491–111491. 5 indexed citations

Hart, William S., Robin N. Thompson, Akiko Makino, et al.. (2023). Contact-number-driven virus evolution: A multi-level modeling framework for the evolution of acute or persistent RNA virus infection. PLoS Computational Biology. 19(5). e1011173–e1011173. 3 indexed citations

Hart, William S., et al.. (2023). Analysis of the risk and pre-emptive control of viral outbreaks accounting for within-host dynamics: SARS-CoV-2 as a case study. Proceedings of the National Academy of Sciences. 120(41). e2305451120–e2305451120. 6 indexed citations

Ashby, Ben, et al.. (2022). Non-pharmaceutical interventions and the emergence of pathogen variants. Evolution Medicine and Public Health. 11(1). 80–89. 6 indexed citations

10.

Tildesley, Michael J., Anna Vassall, Steven Riley, et al.. (2022). Optimal health and economic impact of non-pharmaceutical intervention measures prior and post vaccination in England: a mathematical modelling study. Royal Society Open Science. 9(8). 211746–211746. 14 indexed citations

11.

Thompson, Robin N., et al.. (2022). Evaluating strategies for spatial allocation of vaccines based on risk and centrality. Journal of The Royal Society Interface. 19(187). 20210709–20210709. 4 indexed citations

12.

Leng, Trystan, Edward M. Hill, Alex Holmes, et al.. (2022). Quantifying pupil-to-pupil SARS-CoV-2 transmission and the impact of lateral flow testing in English secondary schools. Nature Communications. 13(1). 1106–1106. 24 indexed citations

13.

Vegvari, Carolin, Sam Abbott, Frank Ball, et al.. (2021). Commentary on the use of the reproduction number R during the COVID-19 pandemic. Statistical Methods in Medical Research. 31(9). 1675–1685. 25 indexed citations

14.

Iwanami, Shoya, Keisuke Ejima, Kwang Su Kim, et al.. (2021). Detection of significant antiviral drug effects on COVID-19 with reasonable sample sizes in randomized controlled trials: A modeling study. PLoS Medicine. 18(7). e1003660–e1003660. 30 indexed citations

15.

Thompson, Robin N., Christopher A. Gilligan, & Nik J. Cunniffe. (2020). Will an outbreak exceed available resources for control? Estimating the risk from invading pathogens using practical definitions of a severe epidemic. Journal of The Royal Society Interface. 17(172). 20200690–20200690. 25 indexed citations

16.

Thompson, Robin N., et al.. (2020). Estimating COVID-19 outbreak risk through air travel. Journal of Travel Medicine. 27(5). 48 indexed citations

17.

Byrne, Helen M., et al.. (2020). Accounting for cross-immunity can improve forecast accuracy during influenza epidemics. Epidemics. 34. 100432–100432. 5 indexed citations

18.

Thompson, Robin N., et al.. (2019). Increased frequency of travel in the presence of cross-immunity may act to decrease the chance of a global pandemic. Philosophical Transactions of the Royal Society B Biological Sciences. 374(1775). 20180274–20180274. 24 indexed citations

19.

Thompson, Robin N., Oliver Morgan, & Katri Jalava. (2019). Rigorous surveillance is necessary for high confidence in end-of-outbreak declarations for Ebola and other infectious diseases. Philosophical Transactions of the Royal Society B Biological Sciences. 374(1776). 20180431–20180431. 27 indexed citations

20.

Witter, Sophie, Tim Ensor, Robin N. Thompson, & Matthew Jowett. (2000). Health Economics for Developing Countries. A Practical Guide.. Queen Margaret University Publications Repository (Queen Margaret University). 28 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact